4.7 Article

Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction

期刊

STRUCTURE
卷 23, 期 8, 页码 1426-1436

出版社

CELL PRESS
DOI: 10.1016/j.str.2015.05.019

关键词

-

资金

  1. Medical Research Council, UK Programme Grant [G0400808]
  2. BBSRC D.Phil. studentship [BB/F016085/1]
  3. MRC Programme Grant [MR/M011984/1]
  4. Wellcome Trust Investigator Award [100298/Z/12/Z]
  5. MRC [G0400808, MR/M011984/1] Funding Source: UKRI
  6. Wellcome Trust [100298/Z/12/Z] Funding Source: Wellcome Trust
  7. Biotechnology and Biological Sciences Research Council [1091176] Funding Source: researchfish
  8. Medical Research Council [G0400808, MR/M011984/1] Funding Source: researchfish

向作者/读者索取更多资源

CD6 is a transmembrane protein with an extracellular region containing three scavenger receptor cysteine rich (SRCR) domains. The membrane proximal domain of CD6 binds the N-terminal immunoglobulin superfamily (IgSF) domain of another cell surface receptor, CD166, which also engages in homophilic interactions. CD6 expression is mainly restricted to T cells, and the interaction between CD6 and CD166 regulates T-cell activation. We have solved the X-ray crystal structures of the three SRCR domains of CD6 and two N-terminal domains of CD166. This first structure of consecutive SRCR domains reveals a nonlinear organization. We characterized the binding sites on CD6 and CD166 and showed that a SNP in CD6 causes glycosylation that hinders the CD6/CD166 interaction. Native mass spectrometry analysis showed that there is competition between the heterophilic and homophilic interactions. These data give insight into how interactions of consecutive SRCR domains are perturbed by SNPs and potential therapeutic reagents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据